 |
|
Management of Recalled Pacemakers and Implantable Cardioverter-Defibrillators
A Decision Analysis Model
Mitesh S. Amin, MD;
David B. Matchar, MD;
Mark A. Wood, MD;
Kenneth A. Ellenbogen, MD
JAMA. 2006;296:412-420.
Context Limited information exists to direct clinical management after an implantable device has been put under advisory. A better understanding of the risks and benefits of device replacement compared with continued clinical follow-up would be helpful to clinicians.
Objective Using the tools of decision analysis, to determine the best management approach (immediate device replacement vs continued monitoring) in the setting of a device advisory.
Design A decision model was constructed to evaluate the risks and benefits associated with immediate device replacement compared with continued monitoring.
Main Outcome Measures Variables considered included indications for device implantation, anticipated course following device failure, device failure rates from the advisory ranging from 0.0001% to 1.0% per year, and device replacement mortality rates ranging from 0.10% to 1.00% per procedure. Device replacement was preferred to continued follow-up when replacement led to greater patient survival.
Results The decision to replace a recalled device depends primarily on the advisory's estimated device failure rate and the likely effects of device failure on mortality. Procedural mortality is an important secondary factor, while patient age and remaining generator life have the least influence on the decision. For pacemaker-dependent patients, advisory device failure rates exceeding 0.3% warrant device replacement in most situations. In patients with implantable cardioverter-defibrillators for primary or secondary prevention, a failure rate associated with an advisory of 3.0% is needed to favor replacement in most cases, decreasing to close to 1.0% as procedural mortality rates decrease to 0.1% or risk of fatal arrhythmias increase to near 20% per year. In cases of pacemaker implantation for non–life-threatening situations (eg, carotid sinus hypersensitivity), most device advisories do not warrant device replacement.
Conclusions The decision to replace a device under advisory is determined primarily by the incidence of device malfunction and the likely effects of device failure. This analysis provides a framework for managing recalled devices in the context of device, patient, and institutional characteristics.
Author Affiliations: Department of Internal Medicine (Dr Amin) and Division of Cardiology (Drs Wood and Ellenbogen), Virginia Commonwealth University Medical Center, Richmond; Department of Medicine and Center for Clinical Health Policy Research, Duke University, and Durham Department of Veterans Affairs Medicine Center, Durham, NC (Dr Matchar).
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices) Developed in Collaboration With the American Association for Thoracic Surgery and Society of Thoracic Surgeons
Epstein et al.
J Am Coll Cardiol 2008;51:e1-e62.
FULL TEXT
ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices): Developed in Collaboration With the American Association for Thoracic Surgery and Society of Thoracic Surgeons
Epstein et al.
Circulation 2008;117:e350-e408.
FULL TEXT
The Year in Epidemiology, Health Services Research, and Outcomes Research
Krumholz and Masoudi
J Am Coll Cardiol 2007;50:2254-2262.
FULL TEXT
A 59-Year-Old Man Considering Implantation of a Cardiac Defibrillator
Zimetbaum
JAMA 2007;297:1909-1916.
ABSTRACT
| FULL TEXT
Guidance for Managing Patients with Devices Named in Advisories
Journal Watch Cardiology 2006;2006:3-3.
FULL TEXT
What's new in the other general journals.
Tonks
BMJ 2006;333:295-296.
FULL TEXT
|
